Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point of care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

For more information, click below.


Subscribers log in here


Related Searches

Treatment and prevention of leptospirosis

INTRODUCTION

Leptospirosis is a zoonosis with protean manifestations caused by the spirochete Leptospira interrogans. Synonyms for the disease include Weil's disease, Swineherd's disease, rice-field fever, cane-cutter fever, swamp fever, mud fever, hemorrhagic jaundice, Stuttgart disease, and Canicola fever.

The treatment and prevention of leptospirosis will be presented here. The epidemiology, microbiology, clinical manifestations, and diagnosis of this disease are discussed separately. (See "Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis".)

TREATMENT

The vast majority of infections with Leptospira are self-limiting. Although penicillins, tetracyclines, chloramphenicol, and erythromycin have antileptospiral activity in vitro and in animal models, it remains controversial whether antimicrobials produce a beneficial effect in mild human leptospirosis since the illness has a variable natural history. Nevertheless, if the illness is severe enough to result in a physician visit and the diagnosis is recognized, antibiotic therapy should be given.

Efficacy — Two small randomized trials have demonstrated benefit from antimicrobial therapy. In a study of 29 patients who received doxycycline (100 mg PO twice daily) or placebo, doxycycline shortened the illness by an average of two days and prevented shedding of the organism in the urine [1]. In a study of 42 patients with severe leptospirosis treated with penicillin (6 million units daily) or placebo, those who received penicillin had fewer days of fever, more rapid resolution of renal function, and a shorter hospital stay; penicillin therapy also prevented urinary shedding [2].

Two randomized trials have compared penicillin (6 million units daily) with ceftriaxone (1 g every 24 hours), cefotaxime (1 g every six hours), and doxycycline (100 mg IV every 12 hours); all regimens were observed to be therapeutically equivalent [3,4]. In one randomized trial of 264 patients with severe leptospirosis in northeastern Thailand comparing cefotaxime, penicillin G and doxycycline, all the regimens had similar efficacy for leptospirosis [4]. Among these patients 132 patients were diagnosed with rickettsial infection; for these patients, treatment with doxycycline was superior to treatment with penicillin G. Therefore, doxycycline or cefotaxime (or ceftriaxone) are appropriate therapies for the treatment of severely ill patients in areas endemic for leptospirosis and rickettsial infection.

       

Subscribers log in here

To continue reading this article you must have access through your hospital or your group practice, log in to your personal subscription, or purchase a personal subscription. For more information, click below.
Literature review current through: Apr 2013. | This topic last updated: Nov 6, 2009.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2013 UpToDate, Inc.
References
Top
  1. McClain JB, Ballou WR, Harrison SM, Steinweg DL. Doxycycline therapy for leptospirosis. Ann Intern Med 1984; 100:696.
  2. Watt G, Padre LP, Tuazon ML, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988; 1:433.
  3. Panaphut T, Domrongkitchaiporn S, Vibhagool A, et al. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003; 36:1507.
  4. Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004; 39:1417.
  5. Hospenthal DR, Murray CK. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrob Agents Chemother 2003; 47:2646.
  6. Phimda K, Hoontrakul S, Suttinont C, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 2007; 51:3259.
  7. Emmanouilides CE, Kohn OF, Garibaldi R. Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report. Clin Infect Dis 1994; 18:1004.
  8. Tunbridge AJ, Dockrell DH, Channer KS, McKendrick MW. A breathless triathlete. Lancet 2002; 359:130.
  9. Chedraui PA, San Miguel G. A case of leptospirosis and pregnancy. Arch Gynecol Obstet 2003; 269:53.
  10. Shaked Y, Shpilberg O, Samra D, Samra Y. Leptospirosis in pregnancy and its effect on the fetus: case report and review. Clin Infect Dis 1993; 17:241.
  11. Tramoni G, Clément HJ, Lopez F, Viale JP. [An unusual case of post partum haemorrhage: leptospirosis infection]. Ann Fr Anesth Reanim 2003; 22:363.
  12. Carles G, Montoya E, Joly F, Peneau C. [Leptospirosis and pregnancy. Eleven cases in French Guyana]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:418.
  13. Dupont H, Dupont-Perdrizet D, Perie JL, et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997; 25:720.
  14. Chawla V, Trivedi TH, Yeolekar ME. Epidemic of leptospirosis: an ICU experience. J Assoc Physicians India 2004; 52:619.
  15. LaRocque RC, Breiman RF, Ari MD, et al. Leptospirosis during dengue outbreak, Bangladesh. Emerg Infect Dis 2005; 11:766.
  16. Pappachan MJ, Mathew S, Aravindan KP, et al. Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India 2004; 17:240.
  17. Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310:497.